Ischemia Modified Albumin Protein (IMA)
IMA
Origin: Human
Host: Human
Native
> 90 %
SDS, WB, Imm, PC
-
- Target See all Ischemia Modified Albumin (IMA) products
- Ischemia Modified Albumin (IMA)
- Protein Type
- Native
- Origin
- Human
- Source
- Human
- Application
- SDS-PAGE (SDS), Western Blotting (WB), Immunogen (Imm), Positive Control (PC)
- Characteristics
- Native Ischemia Modified Albumin (IMA), Natural extract
- Purity
- > 90 %
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Comment
-
Isoelectric Point:
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-80 °C
- Storage Comment
- Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
- Expiry Date
- 12 months
-
- Target
- Ischemia Modified Albumin (IMA)
- Alternative Name
- Ischemia Modified Albumin (IMA Products)
- Molecular Weight
- 68KD
-
You are here:
